Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 37% ± 21% | |
peripheral blood | 11 studies | 23% ± 9% | |
lung | 8 studies | 22% ± 8% | |
heart | 4 studies | 23% ± 5% | |
kidney | 4 studies | 18% ± 3% | |
liver | 4 studies | 27% ± 11% | |
adipose | 4 studies | 28% ± 5% | |
bone marrow | 3 studies | 18% ± 4% | |
intestine | 3 studies | 20% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 24425.16 | 459 / 459 | 100% | 61.82 | 1118 / 1118 |
esophagus | 100% | 16806.43 | 1445 / 1445 | 100% | 68.51 | 183 / 183 |
prostate | 100% | 27967.55 | 245 / 245 | 100% | 67.88 | 500 / 502 |
intestine | 100% | 23595.01 | 965 / 966 | 100% | 56.14 | 525 / 527 |
pancreas | 100% | 20462.73 | 328 / 328 | 99% | 49.14 | 177 / 178 |
bladder | 100% | 19774.19 | 21 / 21 | 99% | 56.53 | 501 / 504 |
thymus | 100% | 27881.59 | 653 / 653 | 99% | 68.72 | 600 / 605 |
lung | 100% | 25543.03 | 578 / 578 | 99% | 56.19 | 1145 / 1155 |
stomach | 100% | 18013.94 | 359 / 359 | 99% | 58.60 | 283 / 286 |
uterus | 100% | 27758.62 | 170 / 170 | 99% | 46.68 | 454 / 459 |
kidney | 100% | 18072.33 | 89 / 89 | 98% | 47.02 | 880 / 901 |
ovary | 100% | 29190.17 | 180 / 180 | 97% | 46.86 | 419 / 430 |
skin | 100% | 20006.03 | 1809 / 1809 | 94% | 47.77 | 445 / 472 |
brain | 94% | 11526.80 | 2479 / 2642 | 100% | 53.41 | 703 / 705 |
adrenal gland | 100% | 17380.19 | 258 / 258 | 93% | 26.20 | 215 / 230 |
liver | 99% | 7816.73 | 223 / 226 | 85% | 23.52 | 344 / 406 |
adipose | 100% | 21789.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 93.02 | 29 / 29 |
spleen | 100% | 39974.89 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.52 | 45 / 45 |
blood vessel | 100% | 20199.61 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 12788.00 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 11758.93 | 841 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 14471.33 | 856 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 84% | 34.27 | 67 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_0007584 | Biological process | response to nutrient |
GO_1902455 | Biological process | negative regulation of stem cell population maintenance |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0032435 | Biological process | negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0030097 | Biological process | hemopoiesis |
GO_0035020 | Biological process | regulation of Rac protein signal transduction |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0045862 | Biological process | positive regulation of proteolysis |
GO_0000432 | Biological process | positive regulation of transcription from RNA polymerase II promoter by glucose |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0007165 | Biological process | signal transduction |
GO_0060544 | Biological process | regulation of necroptotic process |
GO_0032868 | Biological process | response to insulin |
GO_0016485 | Biological process | protein processing |
GO_0046889 | Biological process | positive regulation of lipid biosynthetic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006110 | Biological process | regulation of glycolytic process |
GO_0006111 | Biological process | regulation of gluconeogenesis |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0051963 | Biological process | regulation of synapse assembly |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0045727 | Biological process | positive regulation of translation |
GO_0006915 | Biological process | apoptotic process |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0000423 | Biological process | mitophagy |
GO_0098696 | Biological process | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0046626 | Biological process | regulation of insulin receptor signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0017122 | Cellular component | protein N-acetylglucosaminyltransferase complex |
GO_0044545 | Cellular component | NSL complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0070822 | Cellular component | Sin3-type complex |
GO_0005829 | Cellular component | cytosol |
GO_0042995 | Cellular component | cell projection |
GO_0000123 | Cellular component | histone acetyltransferase complex |
GO_0005634 | Cellular component | nucleus |
GO_0005547 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate binding |
GO_0097363 | Molecular function | protein O-acetylglucosaminyltransferase activity |
GO_0008375 | Molecular function | acetylglucosaminyltransferase activity |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | OGT |
Protein name | O-linked N-acetylglucosamine (GlcNAc) transferase (cDNA FLJ61388, highly similar to UDP-N-acetylglucosamine--peptideN-acetylglucosaminyltransferase 110 kDa subunit) O-linked N-acetylglucosamine (GlcNAc) transferase O-linked N-acetylglucosamine (GlcNAc) transferase (cDNA: FLJ23071 fis, clone LNG05694) UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) |
Synonyms | hCG_19962 |
Description | FUNCTION: Catalyzes the transfer of a single N-acetylglucosamine from UDP-GlcNAc to a serine or threonine residue in cytoplasmic and nuclear proteins resulting in their modification with a beta-linked N-acetylglucosamine (O-GlcNAc) . Glycosylates a large and diverse number of proteins including histone H2B, AKT1, AMPK, ATG4B, CAPRIN1, EZH2, FNIP1, KRT7, LMNA, LMNB1, LMNB2, RPTOR, HOXA1, PFKL, KMT2E/MLL5, MAPT/TAU, TET2, RBL2, RET, NOD2 and HCFC1 . Can regulate their cellular processes via cross-talk between glycosylation and phosphorylation or by affecting proteolytic processing . Involved in insulin resistance in muscle and adipocyte cells via glycosylating insulin signaling components and inhibiting the 'Thr-308' phosphorylation of AKT1, enhancing IRS1 phosphorylation and attenuating insulin signaling (By similarity). Involved in glycolysis regulation by mediating glycosylation of 6-phosphofructokinase PFKL, inhibiting its activity . Plays a key role in chromatin structure by mediating O-GlcNAcylation of 'Ser-112' of histone H2B: recruited to CpG-rich transcription start sites of active genes via its interaction with TET proteins (TET1, TET2 or TET3) . As part of the NSL complex indirectly involved in acetylation of nucleosomal histone H4 on several lysine residues . O-GlcNAcylation of 'Ser-75' of EZH2 increases its stability, and facilitating the formation of H3K27me3 by the PRC2/EED-EZH2 complex . Stabilizes KMT2E/MLL5 by mediating its glycosylation, thereby preventing KMT2E/MLL5 ubiquitination . Regulates circadian oscillation of the clock genes and glucose homeostasis in the liver (By similarity). Stabilizes clock proteins BMAL1 and CLOCK through O-glycosylation, which prevents their ubiquitination and subsequent degradation (By similarity). Promotes the CLOCK-BMAL1-mediated transcription of genes in the negative loop of the circadian clock such as PER1/2 and CRY1/2. O-glycosylates HCFC1 and regulates its proteolytic processing and transcriptional activity . Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1 . Regulates mitochondrial motility in neurons by mediating glycosylation of TRAK1 (By similarity). Promotes autophagy by mediating O-glycosylation of ATG4B . Acts as a regulator of mTORC1 signaling by mediating O-glycosylation of RPTOR and FNIP1: O-GlcNAcylation of RPTOR in response to glucose sufficiency promotes activation of the mTORC1 complex . .; FUNCTION: [Isoform 2]: The mitochondrial isoform (mOGT) is cytotoxic and triggers apoptosis in several cell types including INS1, an insulinoma cell line. .; FUNCTION: [Isoform 4]: Has N-acetylglucosaminyltransferase activity: glycosylates proteins, such as HNRNPU, NEUROD1, NUP62 and PDCD6IP . Displays specific substrate selectivity compared to other isoforms . . |
Accessions | ENST00000699782.1 ENST00000699749.1 ENST00000444774.3 A0A8V8TP98 A0A8V8TQJ1 C9JZL3 Q548W1 ENST00000373701.7 [O15294-3] A0A8V8TP17 ENST00000699779.1 A0A8V8TPA3 ENST00000699784.1 ENST00000699781.1 ENST00000699780.1 A0A8V8TQ37 ENST00000699785.1 O15294 ENST00000699750.1 A0A8V8TNT2 ENST00000699783.1 B4DTL6 ENST00000373719.8 [O15294-1] Q9H5T3 A0A8V8TQ64 |